Skip to main content
Top
Published in: Medical Oncology 2/2011

01-06-2011 | Original Paper

Growth inhibitory effects of DJ-1-small interfering RNA on laryngeal carcinoma Hep-2 cells

Authors: Zhisen Shen, Zhen Jiang, Dong Ye, Bingxiu Xiao, Xingang Zhang, Junming Guo

Published in: Medical Oncology | Issue 2/2011

Login to get access

Abstract

Cancer of the larynx is the commonest head and neck squamous cell carcinoma. The DJ-1 gene is a novel mitogen-dependent oncogene. Survivin is a structurally unique member of the inhibitors of apoptosis proteins. DJ-1 and survivin play important roles in carcinogenesis. The function of DJ-1, and the relationship between DJ-1 and survivin in laryngeal carcinoma, has never been explored. Small interfering RNAs (siRNAs) directed against the DJ-1 gene were initially transfected into laryngeal carcinoma Hep-2 cells with liposome. The viability of Hep-2 cells was then detected by the MTT assay. The changes in cell-cycle distribution were monitored by flow cytometry. Finally, changes in DJ-1 and survivin genes mRNA and protein levels were evaluated by semi-quantitative RT-PCR and Western blotting, respectively. Blocking expression of the DJ-1 gene with DJ-1-siRNA significantly suppressed the viability of Hep-2 cells. Treatment with DJ-1-siRNA resulted in a G2/M accumulation. Expressions of DJ-1 and survivin gene mRNA and protein levels were suppressed by DJ-1-siRNA in a dose-dependent manner. These data indicate, for the first time, that the DJ-1 gene may have an important role in the carcinogenesis of laryngeal carcinoma.
Literature
1.
go back to reference Farhadieh RD, et al. Radiotherapy in larynx squamous cell carcinoma is not associated with an increased diagnosis of second primary tumours. Clin Oncol (R Coll Radiol). 2009;21:315–9. Farhadieh RD, et al. Radiotherapy in larynx squamous cell carcinoma is not associated with an increased diagnosis of second primary tumours. Clin Oncol (R Coll Radiol). 2009;21:315–9.
2.
go back to reference Benasso M, et al. Treatment with cisplatin and fluorouracil alternating with radiation favourably affects prognosis of inoperable squamous cell carcinoma of the head and neck: results of a multivariate analysis on 273 patients. Ann Oncol. 1997;8:773–9.PubMedCrossRef Benasso M, et al. Treatment with cisplatin and fluorouracil alternating with radiation favourably affects prognosis of inoperable squamous cell carcinoma of the head and neck: results of a multivariate analysis on 273 patients. Ann Oncol. 1997;8:773–9.PubMedCrossRef
3.
go back to reference Lu B, et al. Survivin as a therapeutic target for radiation sensitization in lung cancer. Cancer Res. 2004;64:2840–5.PubMedCrossRef Lu B, et al. Survivin as a therapeutic target for radiation sensitization in lung cancer. Cancer Res. 2004;64:2840–5.PubMedCrossRef
4.
go back to reference Kawasaki H, et al. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer. 2001;91:2026–32.PubMedCrossRef Kawasaki H, et al. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer. 2001;91:2026–32.PubMedCrossRef
5.
go back to reference Fan LF, Dong WG, Jiang CQ, Qian Q, Yu QF. Role of Hypoxia-inducible factor-1 alpha and survivin in colorectal carcinoma progression. Int J Colorectal Dis. 2008;23:1057–64.PubMedCrossRef Fan LF, Dong WG, Jiang CQ, Qian Q, Yu QF. Role of Hypoxia-inducible factor-1 alpha and survivin in colorectal carcinoma progression. Int J Colorectal Dis. 2008;23:1057–64.PubMedCrossRef
6.
go back to reference Nassar A, Sexton D, Cotsonis G, Cohen C. Survivin expression in breast carcinoma: correlation with apoptosis and prognosis. Appl Immunohistochem Mol Morphol. 2008;16:221–6.PubMedCrossRef Nassar A, Sexton D, Cotsonis G, Cohen C. Survivin expression in breast carcinoma: correlation with apoptosis and prognosis. Appl Immunohistochem Mol Morphol. 2008;16:221–6.PubMedCrossRef
7.
go back to reference Liu L, Zhang M, Zou P. Expression of PLK1 and survivin in diffuse large B-cell lymphoma. Leuk Lymphoma. 2007;48:2179–83.PubMedCrossRef Liu L, Zhang M, Zou P. Expression of PLK1 and survivin in diffuse large B-cell lymphoma. Leuk Lymphoma. 2007;48:2179–83.PubMedCrossRef
8.
go back to reference Taira T, Takahashi K, Kitagawa R, Iguchi-Ariga SM, Ariga H. Molecular cloning of human and mouse DJ-1 genes and identification of Sp1-dependent activation of the human DJ-1 promoter. Gene. 2001;263:285–92.PubMedCrossRef Taira T, Takahashi K, Kitagawa R, Iguchi-Ariga SM, Ariga H. Molecular cloning of human and mouse DJ-1 genes and identification of Sp1-dependent activation of the human DJ-1 promoter. Gene. 2001;263:285–92.PubMedCrossRef
9.
go back to reference MacKeigan JP, et al. Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. Cancer Res. 2003;63:6928–34.PubMed MacKeigan JP, et al. Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. Cancer Res. 2003;63:6928–34.PubMed
10.
go back to reference Hod Y. Differential control of apoptosis by DJ-1 in prostate benign and cancer cells. J Cell Biochem. 2004;92:1221–33.PubMedCrossRef Hod Y. Differential control of apoptosis by DJ-1 in prostate benign and cancer cells. J Cell Biochem. 2004;92:1221–33.PubMedCrossRef
11.
12.
go back to reference Shinbo Y, Taira T, Niki T, Iguchi-Ariga SM, Ariga H. DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3. Int J Oncol. 2005;26:641–8.PubMed Shinbo Y, Taira T, Niki T, Iguchi-Ariga SM, Ariga H. DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3. Int J Oncol. 2005;26:641–8.PubMed
13.
go back to reference Taira T, et al. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 2004;5:213–8.PubMedCrossRef Taira T, et al. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 2004;5:213–8.PubMedCrossRef
14.
go back to reference Yokota T, et al. Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun. 2003;312:1342–8.PubMedCrossRef Yokota T, et al. Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun. 2003;312:1342–8.PubMedCrossRef
15.
go back to reference Nagakubo D, et al. DJ-1, a novel oncogene product which transforms mouse NIH3T3 cells in cooperation with H-ras. Biochem Biophys Res Commun. 1997;231:509–13.PubMedCrossRef Nagakubo D, et al. DJ-1, a novel oncogene product which transforms mouse NIH3T3 cells in cooperation with H-ras. Biochem Biophys Res Commun. 1997;231:509–13.PubMedCrossRef
16.
go back to reference Shi W, et al. Dysregulated PTEN- PKB and negative receptor status in human breast cancer. Int J Cancer. 2003;104:195–203.PubMedCrossRef Shi W, et al. Dysregulated PTEN- PKB and negative receptor status in human breast cancer. Int J Cancer. 2003;104:195–203.PubMedCrossRef
17.
go back to reference Le Naour F, et al. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res. 2001;7:3328–35.PubMed Le Naour F, et al. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res. 2001;7:3328–35.PubMed
18.
go back to reference Suzuki A, et al. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene. 2000;19:3225–34.PubMedCrossRef Suzuki A, et al. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene. 2000;19:3225–34.PubMedCrossRef
19.
go back to reference Wu RC, Li X, Schonthal AH. Transcriptional activation of P21WAF1 by PTEN/MMAC1 tumor suppressor. Mol Cell Biochem. 2000;203:59–71.PubMedCrossRef Wu RC, Li X, Schonthal AH. Transcriptional activation of P21WAF1 by PTEN/MMAC1 tumor suppressor. Mol Cell Biochem. 2000;203:59–71.PubMedCrossRef
20.
22.
go back to reference Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP. DJ-1, a cancer-and Parkindon’s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA. 2006;103:15091–6.PubMedCrossRef Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP. DJ-1, a cancer-and Parkindon’s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA. 2006;103:15091–6.PubMedCrossRef
23.
go back to reference Junn E, et al. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc Natl Acad Sci USA. 2005;102:9691–6.PubMedCrossRef Junn E, et al. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc Natl Acad Sci USA. 2005;102:9691–6.PubMedCrossRef
24.
go back to reference Wu F, Liang YQ, Huang ZM. The expression of DJ-1 gene in human hepatocellular carcinoma and its relationship with tumor invasion and metastasis. Zhonghua Gan Zang Bing Za Zhi. 2009;17:203–6.PubMed Wu F, Liang YQ, Huang ZM. The expression of DJ-1 gene in human hepatocellular carcinoma and its relationship with tumor invasion and metastasis. Zhonghua Gan Zang Bing Za Zhi. 2009;17:203–6.PubMed
25.
go back to reference Carter BZ, Milella M, Altieri DC, Andreeff M. Cytokine-regulated expression of survivin in myeloid leukemia. Blood. 2001;97:2784–90.PubMedCrossRef Carter BZ, Milella M, Altieri DC, Andreeff M. Cytokine-regulated expression of survivin in myeloid leukemia. Blood. 2001;97:2784–90.PubMedCrossRef
26.
go back to reference Suzuki A, et al. Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene. 2000;19:1346–53.PubMedCrossRef Suzuki A, et al. Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene. 2000;19:1346–53.PubMedCrossRef
Metadata
Title
Growth inhibitory effects of DJ-1-small interfering RNA on laryngeal carcinoma Hep-2 cells
Authors
Zhisen Shen
Zhen Jiang
Dong Ye
Bingxiu Xiao
Xingang Zhang
Junming Guo
Publication date
01-06-2011
Publisher
Springer US
Published in
Medical Oncology / Issue 2/2011
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9474-7

Other articles of this Issue 2/2011

Medical Oncology 2/2011 Go to the issue